Rebound Therapeutics

About:

Rebound Therapeutics is a medical device company.

Top Investors: Invus, Wexford Capital, HBM-MedFocus

Description:

Rebound has progressed rapidly over the past 18 months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive surgical procedures. In addition to rapid product development of its initial products, Rebound has assembled a world-class Scientific Advisory Board of leading MIS physicians, filed 14 patents to solidify its intellectual property platform and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.

Total Funding Amount:

$16.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Irvine, California, United States

Founded Date:

2015-01-01

Founders:

Alex Thomson, Lisa Zindel

Number of Employees:

11-50

Last Funding Date:

2017-07-25

IPO Status:

Private

Industries: